A. J. Bredenoord
Academic Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by A. J. Bredenoord.
Gut | 2016
An Moonen; Vito Annese; Ann Belmans; A. J. Bredenoord; Stanislas Bruley des Varannes; Mario Costantini; Bertrand Dousset; Ji Elizalde; Uberto Fumagalli; Marianne Gaudric; Antonio Merla; André J. P. M. Smout; Jan Tack; Giovanni Zaninotto; Olivier R. Busch; Guy E. Boeckxstaens
Objective Achalasia is a chronic motility disorder of the oesophagus for which laparoscopic Heller myotomy (LHM) and endoscopic pneumodilation (PD) are the most commonly used treatments. However, prospective data comparing their long-term efficacy is lacking. Design 201 newly diagnosed patients with achalasia were randomly assigned to PD (n=96) or LHM (n=105). Before randomisation, symptoms were assessed using the Eckardt score, functional test were performed and quality of life was assessed. The primary outcome was therapeutic success (presence of Eckardt score ≤3) at the yearly follow-up assessment. The secondary outcomes included the need for re-treatment, lower oesophageal sphincter pressure, oesophageal emptying and the rate of complications. Results In the full analysis set, there was no significant difference in success rate between the two treatments with 84% and 82% success after 5u2005years for LHM and PD, respectively (p=0.92, log-rank test). Similar results were obtained in the per-protocol analysis (5-year success rates: 82% for LHM vs 91% for PD, p=0.08, log-rank test). After 5u2005years, no differences in secondary outcome parameter were observed. Redilation was performed in 24 (25%) of PD patients. Five oesophageal perforations occurred during PD (5%) while 12 mucosal tears (11%) occurred during LHM. Conclusions After at least 5u2005years of follow-up, PD and LHM have a comparable success rate with no differences in oesophageal function and emptying. However, 25% of PD patients require redilation during follow-up. Based on these data, we conclude that either treatment can be proposed as initial treatment for achalasia. Trial registration numbers Netherlands trial register (NTR37) and Current Controlled Trials registry (ISRCTN56304564).
Neurogastroenterology and Motility | 2012
P. W. Weijenborg; Filippo Cremonini; Andreas J. Smout; A. J. Bredenoord
Backgroundu2002 Symptomatic response to proton pump inhibitor (PPI) therapy in patients with non‐erosive reflux disease (NERD) is often reported as lower than in patients with erosive reflux disease (ERD). However, the definition of NERD differs across clinical trials. This meta‐analysis aims to estimate the rate of symptom relief in response to PPI in NERD patients.
Neurogastroenterology and Motility | 2014
B. F. Kessing; A. J. P. M. Smout; Roelof J. Bennink; N. Kraaijpoel; Jac Oors; A. J. Bredenoord
The 5‐HT4 receptor agonist prucalopride is a prokinetic drug which improves colonic motility. Animal data and in vitro studies suggest that prucalopride also affects gastric and esophageal motor function. We aimed to assess the effect of prucalopride on gastric emptying, esophageal motility, and gastro‐esophageal reflux in man.
Alimentary Pharmacology & Therapeutics | 2011
Boudewijn F. Kessing; José M. Conchillo; A. J. Bredenoord; A. J. P. M. Smout; A. A. M. Masclee
Aliment Pharmacol Ther 2011; 33: 650–661
Archive | 2011
Boudewijn F. Kessing; José M. Conchillo; A. J. Bredenoord; André Smout; Ad Masclee
Aliment Pharmacol Ther 2011; 33: 650–661
Neurogastroenterology and Motility | 2006
J. M. Conchillo; M. Selimah; A. J. Bredenoord; M. Samsom; A. J. P. M. Smout
Abstractu2002 Oesophageal emptying can be assessed by radiographic and scintigraphic tests with radiation exposure or by multichannel intraluminal impedance monitoring (MII). The aim of this study was to evaluate the applicability of MII for the assessment of oesophageal emptying in achalasia patients. In 10 achalasia patients, impedance tracings were scored independently by three observers after ingestion of a 100‐mL barium bolus. Bolus clearance time (BCT) and height of barium column were scored using fluoroscopic images acquired at 20‐s intervals. All patients showed a low baseline impedance level in the distal oesophagus. Air trapping in the proximal oesophagus was detected in nine patients. BCT on MII was similar to that on fluoroscopy in 40–70% of the patients. Correlations between height of barium on fluoroscopy and fluid level on MII were poor to moderate at different time intervals. Concordance (Kendalls coefficient) between the three observers for assessment of fluid level on MII was 0.31 (Pu2003=u20030.04) at 1 and 5u2003min, 0.26 (Pu2003=u20030.08) at 10 and 0.44 (Pu2003=u20030.01) at 15u2003min. We conclude that in achalasia patients, low baseline impedance levels and air entrapment in the proximal oesophagus limit the value of intraluminal impedance monitoring as a test of oesophageal emptying.
Neurogastroenterology and Motility | 2012
B. F. Kessing; A. J. Bredenoord; A. J. P. M. Smout
Backgroundu2002 Esophageal impedance monitoring has made it possible to distinguish two types of belches, designated gastric and supragastric. We aimed to compare the esophageal pressure characteristics during supragastric belches and gastric belches using combined high‐resolution manometry and impedance monitoring.
Neurogastroenterology and Motility | 2015
T. V. K. Herregods; M. Troelstra; P. W. Weijenborg; A. J. Bredenoord; Andreas J. Smout
In patients with typical reflux symptoms that persist despite proton pump inhibitors (PPIs) it is sometimes overlooked that treatment fails due to the presence of other disorders than gastroesophageal reflux disease (GERD). The aim of this study was to determine the underlying cause of reflux symptoms not responding to PPI therapy in tertiary referral patients.
Alimentary Pharmacology & Therapeutics | 2012
Boudewijn F. Kessing; A. J. Bredenoord; M. Velosa; A. J. P. M. Smout
Patients with gastro‐oesophageal reflux disease (GERD) frequently report excessive belching but it is not known what determines the severity of these complaints.
Alimentary Pharmacology & Therapeutics | 2007
J. M. Conchillo; M. Selimah; A. J. Bredenoord; M. Samsom; A. J. P. M. Smout
Background Frequent belching is a common symptom in patients with functional dyspepsia with a reported incidence up to 80%. We hypothesized that patients with functional dyspepsia possibly have a higher frequency of belching than healthy subjects secondary to frequent air swallowing.